Eldorado Gold (EGO) is down about 3% as the market reacts to a new round of sell-side caution focused on valuation and delivery risk. A key catalyst is an April 15, 2026 note that lowered TD Cowen’s price objective to $40 from $45 while reiterating a hold stance, pressuring sentiment into today’s session. (defenseworld.net)

Investors continue to key in on Skouries in Greece, which Eldorado positioned as the near-term growth inflection but also the main execution variable. In its February 19, 2026 guidance release, Eldorado said first concentrate production at Skouries was delayed by roughly one quarter to early Q3 2026, with commercial production expected in Q4 2026, and it also flagged incremental construction project capital associated with the delay. That combination—later cash-flow ramp timing plus added spend—can amplify downside moves on weak days for risk appetite. (eldoradogold.com)

The next swing factors are any updates on commissioning progress at Skouries, confirmation that Q4 2026 commercial production remains intact, and any refreshed consolidated cost guidance once Skouries advances through ramp-up. With the stock reacting sharply to target changes and schedule sensitivity, near-term trading is likely to stay headline-driven around project milestones and analyst revisions. (eldoradogold.com)